Battiwalla, Minoo <br/><br/>
HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies.  [electronic resource] 

 -  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation  Aug 2012 
 - 1302-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1523-6536 
<br/><br/><label>Standard No.: </label>10.1016/j.bbmt.2012.02.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Child<br/>Child, Preschool<br/>Disease-Free Survival<br/>Female<br/>Graft vs Host Disease--immunology<br/>HLA-DR Serological Subtypes--immunology<br/>Hematologic Neoplasms--immunology<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Histocompatibility--immunology<br/>Histocompatibility Testing<br/>Humans<br/>Infant<br/>Male<br/>Middle Aged<br/>Siblings<br/>Survival Analysis<br/>Tissue Donors<br/>Young Adult